TapImmune Inc.

(TPIV) Trade

By |

Profile

TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.

Contact Information

Website: www.tapimmune.com
Email: investor.relations@tapimmune.com
Main Phone: +1 904 862-6490
Address: 5 West Forsyth Street
Address 2: Suite 200
State: FL
City / Town: Jacksonville
Country: USA
Postal Code: 32202

Issuer Information

Exchange: NSC
CEO: Peter L. Hoang
Employees: 7
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 9.95 $ 0.32 (3.32%)
Last Price 9.95 Change $ 0.32 Change % 3.32 Tick N/A
Bid 9.95 Bid Size 300.00 Ask 10.35 Ask Size 200.00
Open 9.62 High 10.60 Low 9.23 Prev Close 9.63
Last Trade Volume 526,763 52 Wk Hi 13.55 52 Wk Low 2.58
Market Cap 136.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 13,710,544.00 EPS (TTM) -1.35 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 9
Number of Buys 0 7
Number of Sells 0 2
Net Activity 0 317936
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Denis Corin 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 5 5 5 5
Mean Target Price Estimate 5 5 5 5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/16/18 03/16/18 03/16/18 03/16/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 2 2 2